DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary


DiaMedica Therapeutics is owned by 13.34% institutional investors, 26.23% insiders, and 60.43% retail investors. Cooperman leon g is the largest institutional shareholder, holding 3.69% of DMAC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.75% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics13.34%26.23%60.43%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g1.40M3.69%$4.13M
Vanguard group1.02M2.68%$3.00M
First manhattan co. llc.839.08K2.21%$2.48M
Paragon associates & paragon associates ii joint venture482.61K1.27%$1.42M
Bleichroeder lp382.32K1.01%$1.13M
Geode capital management236.89K0.62%$699.00K
Northern trust120.39K0.32%$355.15K
Blackrock105.30K0.28%$310.64K
Morgan stanley86.20K0.23%$254.29K
State street68.73K0.18%$202.75K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture482.61K3.48%$1.42M
Bleichroeder lp382.32K0.34%$1.13M
Cooperman leon g1.40M0.17%$4.13M
Catalyst financial partners38.46K0.02%$113.45K
Magnolia capital advisors10.00K0.01%$29.50K
First manhattan co. llc.839.08K0.01%$2.48M
Naples money management2.98K0.01%$8.79K
Stonebridge capital advisors20.00K0.01%$59.00K
Legend financial advisors1.00K0.00%$2.95K
Massmutual trust co fsb/adv4.82K0.00%$14.23K

Top Buyers

HolderShares% AssetsChange
Cooperman leon g1.40M0.17%516.38K
Bleichroeder lp382.32K0.34%160.00K
Lpl financial17.50K-17.50K
Magnolia capital advisors10.00K0.01%10.00K
Vanguard group1.02M0.00%3.88K

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp43.37K--165.96K
Aristides capital---106.33K
Bank of new york mellon---24.00K
Paragon associates & paragon associates ii joint venture482.61K3.48%-17.39K
Jane street group---15.09K

New Positions

HolderShares% AssetsChangeValue
Lpl financial17.50K-17.50K$51.63K
Magnolia capital advisors10.00K0.01%10.00K$29.50K

Sold Out

HolderChange
Toronto dominion bank-24.00
Wells fargo & company/mn-175.00
Federation des caisses desjardins du quebec-230.00
Ubs group-1.93K
Jane street group-15.09K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202434-5,063,14310.09%136.69%1250.00%912.50%
Mar 31, 202434-15.00%4,599,12919.69%1413.77%8-55.56%8100.00%
Dec 31, 2023402.56%3,842,585-9.61%104.18%18-10.00%4-42.86%
Sep 30, 20233918.18%4,251,27021.78%158.94%2025.00%740.00%
Jun 30, 20233326.92%3,490,91835.95%1314.00%1677.78%525.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv747.20K1.75%-
Vanguard Institutional Extnd Mkt Idx Tr253.73K0.59%-
Fidelity Extended Market Index152.40K0.36%25.24K
Jacob Discovery Fd Instl122.73K0.29%-5.00K
iShares Micro-Cap ETF55.12K0.13%-
Fidelity Total Market Index48.90K0.11%26.92K
Fidelity Nasdaq Composite Index42.74K0.10%-
BlackRock Extended Equity Market K39.62K0.09%-17.00
Fidelity Series Total Market Index35.16K0.08%8.89K
Vanguard Balanced Index Inv24.55K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 28, 2024Von Koch Thomas-Buy$3.00M
Jun 28, 2024STAHLBERG JAN-Buy$3.00M
Nov 16, 2023Wambeke David J. Chief Business OfficerBuy$49.20K
Jun 23, 2023Von Koch Thomas-Buy$5.00M
Jun 23, 2023Giuffre Randall Michael-Buy$254.15K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q28-
2023 Q1--

DMAC Ownership FAQ


Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 13.34%, followed by 26.23% insiders and 60.43% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 44.97%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (1.4M shares, 3.69%), Vanguard group (1.02M shares, 2.68%), and First manhattan co. llc. (839.08K shares, 2.21%). Together, they hold 8.58% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

Yes, BlackRock owns 0.28% of DiaMedica Therapeutics, totaling 105.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 310.64K$. In the last quarter, BlackRock increased its holdings by 1.93K shares, a 1.87% change.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.48% of its assets in 482.61K DiaMedica Therapeutics shares, valued at 1.42M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.75% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools